Quarterly report · Q1
8095.TEDINET S100T9LM
Period2023-12-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.4bn | 2023-12-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-12-01 → 2023-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.8bn | 2022-12-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥454m | 2023-12-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | −¥93m | 2022-12-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥480m | 2023-12-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-12-01 → 2023-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥64m | 2022-12-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥393m | 2023-12-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | −¥86m | 2022-12-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥249m | 2023-12-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2022-12-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥207m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥249m | 2023-12-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | −¥208m | 2022-12-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥65.9bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥67.3bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.2bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥38.7bn | at 2023-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥28.7bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥26.5bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.7bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2023-11-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥6.32 | 2023-12-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.47 | 2022-12-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.25 | 2022-12-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.3% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.5% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-02-29 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-02-29 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-02-29 | −¥31m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-02-29 | −¥505m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-02-29 | −¥505m |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-02-29 | ¥22m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥5.9bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥5.5bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥371m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥76m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥3.0bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥3.0bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥14m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥93m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥2.5bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥2.5bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥20m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥112m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue | 2023-12-01 → 2024-02-29 | ¥2.5bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue external | 2023-12-01 → 2024-02-29 | ¥2.4bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥100m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | segment profit | 2023-12-01 → 2024-02-29 | ¥182m |
| —segment total | revenue | 2023-12-01 → 2024-02-29 | ¥13.9bn |
| —segment total | revenue external | 2023-12-01 → 2024-02-29 | ¥13.4bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥505m |
| —segment total | segment profit | 2023-12-01 → 2024-02-29 | ¥463m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-02-29 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-02-29 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-02-29 | ¥505m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-02-29 | ¥432m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-02-28 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-02-28 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥55,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-02-28 | −¥23m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-02-28 | −¥429m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-02-28 | −¥429m |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-02-28 | ¥60m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥4.9bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥4.6bn |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥341m |
| jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | ¥26m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥4.2bn |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥42m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥17m |
| jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥105m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue external | 2022-12-01 → 2023-02-28 | ¥2.0bn |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥61m |
| jpcrp040300-q1r_E02585-000Medicalreportable segment | segment profit | 2022-12-01 → 2023-02-28 | −¥9m |
| —segment total | revenue | 2022-12-01 → 2023-02-28 | ¥13.2bn |
| —segment total | revenue external | 2022-12-01 → 2023-02-28 | ¥12.8bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥429m |
| —segment total | segment profit | 2022-12-01 → 2023-02-28 | −¥130m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-02-28 | ¥13.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-02-28 | ¥12.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-02-28 | ¥429m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-02-28 | −¥153m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 447
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)PwC Japan有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)五代 英紀 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新田 將貴 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12785442000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 13426497000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 51984426000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -64164000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 480260000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1363948000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -206794000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 249432000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1162744000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -221864000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 472564000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2091505000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 26505029000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 28731597000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 28601522000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 63602750000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 65912426000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 67254750000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -5.25 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 6.32 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 29.47 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.415 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.433 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.423 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 40884504 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 40982832 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 40884504 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 40982832 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 733200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 7300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 40058000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 400580 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 86004 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 40884504 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 400580 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 733200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 733200 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |